Houston, TX, United States of America

Hagop Kantarjian

This inventor holds 1 USPTO granted patent. Top assignee: Shire Biochem, Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hagop Kantarjian. Retrieved from https://idiyas.com/inventor/hagop-kantarjian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hagop Kantarjian: Innovator in Leukemia Treatment

Introduction

Hagop Kantarjian is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of medicine, particularly in the treatment of leukemia. His innovative work has led to the development of methods that aim to improve patient outcomes.

Latest Patents

Hagop Kantarjian holds 1 patent for his groundbreaking work titled "Methods of treating leukemia." This patent reflects his dedication to advancing medical science and providing new solutions for patients suffering from this challenging disease.

Career Highlights

Kantarjian is associated with Shire Biochem, Inc., where he continues to work on innovative treatments. His career is marked by a commitment to research and development in the field of oncology, making him a respected figure among his peers.

Collaborations

Throughout his career, Kantarjian has collaborated with notable colleagues, including Jacques Jolivet and Francis J. Giles. These partnerships have fostered an environment of innovation and have contributed to the advancement of leukemia treatment methodologies.

Conclusion

Hagop Kantarjian's contributions to the field of leukemia treatment exemplify the impact of dedicated inventors in medicine. His work continues to inspire advancements that can change lives for the better.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…